An open reading frame with the characteristics of a glycoprotein-coding sequence was identified by nucleotide sequencing of human cytomegalovirus (HCMV) genomic DNA (11, 25, 40) .
Infection with human cytomegalovirus (HCMV), a betaherpesvirus, is a relatively common occurrence, as shown by seropositivity rates in adult populations (43) , but illness is frequently mild or subclinical. However, in those individuals with immature immune systems, such as the fetus and neonate, or in immunosuppressed individuals, such as those undergoing organ grafting or patients with the acquired immune deficiency syndrome, infection with HCMV can cause significant morbidity and mortality (11, 25, 40) .
The development of rational strategies of vaccination and immunotherapy to prevent HCMV infection or to limit illness in those at high risk depends upon both a better understanding of the biology of the virus and detailed analysis of virion components that are able to elicit immune respotises. It is expected that the target antigens for antibodies that are able to neutralize virus infectivity will be the virus-encoded glycoproteins that are inserted into the envelope of the mature virus particles. Analysis of these proteins has, however, been complicated by several factors. The virus gtows slowly and in a limited number of cell types and fails to shut off host cell synthesis; infected cells display an avid immunoglobulin Fc binding activity (13) ; and the virion glycoproteins have complex product precursor relationships (30) and form multimeric complexes (4, 12, 18, 20) .
In several reports monoclonal antibodies have been desciibed that are reactive with HCMV glycoproteins that are able to neutralize virus infectivity in vitro (5, 8, 18, 29, 32, 33) . Individually purified or expressed HCMV glycoproteins have also been shown to elicit neutralizing responses in experimental animals (8, 16, 31 (39) . A stretch of N-terminal hydrophobic amino acids consistent with signal peptide and a C-terminal-associated stretch of hydrophobic residues consistent with a transmembrane region were identified.
The predicted translation product of the open reading frame was compared with glycoprotein genes of other herpesviruses by using the FAST P computer program (21) , and the matches were analyzed with the DIAGON computer program (38) . This revealed homology with glycoprotein H (gH) of herpes simplex virus (HSV) (15, 24) , the EpsteinBarr virus (EBV) BXLF2 gene product (1), and varicellazoster virus (VZV) gpIII (19) . In previous analyses (9, 10, 24) , it has been established that these three gene products are homologous and that the homology is restricted to the carboxy-terminal region of the molecule. The homology was weak and was confined to the C-terminal half of the reading frame (Fig. 1) (Fig. 3) . A control rabbit antiserum sample raised against a HSV peptide did not precipitate this protein, although it did react with the 116-kDa 1-galactosidase. A band with a slightly greater electrophoretic mobility than that of HCMV-gH was common to all vaccinia virus-infected cells and probably represents the breakthrough of a vaccinia virus protein. In HCMV-infected MRC5 cell lysates, multiple polypeptides were precipitated with the anti-HCMV antisera, including a prominent 86-kDa band which may represent gH.
Next, a panel of murine monoclonal antibodies raised against HCMV was screened for reactivity to the gH-VAC recombinant viruses. An antibody designated HCMV-16 immunoprecipitated an 86-kDa protein from both HCMV and HCMV-gH-VAC-infected cell lysates (Fig. 4) . It was repeatedly noted that the electrophoretic mobility of the protein precipitated from HCMV-infected cell lysates was slightly greater than that seen from HCMV-gH-VAC-infected cell lysates. When cells infected with HCMV or vaccinia virus recombinants were labeled with [35S]methionine in the presence of 10 ,ug of tunicamycin per ml, the 86-kDa band was no longer detectable by immunoprecipitation with either HCMV-16 monoclonal antibody or rabbit anti-HCMV virion serum (data not shown).
Cellular localization of HCMV-gH. The location of gH in HCMV-gH-VAC-infected cells was analyzed by indirect immunofluorescence by using HCMV-16 ascitic fluid on recombinant and WT vaccinia virus-infected CV1 cells. No expression of the antigen at the cell surface was seen (Fig.  5) . However, when cells were permeabilized by treatment with Triton X-100 before antibody was added, diffuse, fibrillar cytoplasmic staining and striking nuclear membrane staining of HCMV-gH-VAC-infected cells were observed. HCMV-gH is a target for neutralizing antibody. Monoclonal antibody HCMV-16 (ascites fluid) was shown to neutralize HCMV infectivity strongly in vitro, both in the presence and absence of rabbit complement (Fig. 6 ). This is in contrast to the complement-dependent neutralization seen with two monoclonal antibodies with specificity for HCMV-gB. HCMV-gH has an epitope that is a target for in vitro neutralization of virus infectivity, as shown by the potent complement-independent activity seen with a gH-specific murine monoclonal antibody. The complement independence is in contrast to five anti-HCMV gB monoclonal antibodies studied in this laboratory which neutralize the virus infectivity only in the presence of complement. While these observations are consistent with those of , who have also described a monoclonal antibody directed against an 86-kDa HCMV glycoprotein displaying complement-independent neutralizing activity, it has yet to be determined whether these proteins are the same.
Both the monoclonal antibody and polyclonal antisera used in this study precipitated polypeptides of approxi- [14] and vaccinia virus recombinants [see above]), it is possible that the cellular distribution of the gene products may also be influenced by other factors. The kinetics of processing of cloned gene products, and hence their transport, may differ from those in infected cells, as has been shown for HSV type 2 gD (17) . Johnson and Smiley (17) have also suggested that the distribution of the glycoprotein may be influenced by the presence of other viral gene products. Furthermore, mutants of HSV have been isolated that exhibit greatly reduced cell surface expression of viral glycoproteins, despite normal levels of glycoprotein synthesis (27) , and the coding region involved has recently been sequenced and found to be conserved in EBV (28) . It is therefore conceivable that the normal transport of HCMVgH by the Golgi complex to the cell surface requires other HCMV-specific gene products; indeed, HCMV infection is known to modify the ultrastructure of the Golgi complex (37) . It is equally possible that the vaccinia virus infection produces an intracellular environment that is detrimental to the proper processing of HCMV-gH, the proper translocation of HCMV-gH, or both.
Homologs of HSV type 1 gH have been found in members of the alpha, beta, and gammaherpesvirus subgroups (15, 24; this report); and it is therefore probable that, together with gB, gH will be found in all herpesviruses. The functions of gH are unknown, but HSV type 1 antibody to gH efficiently neutralizes virus infectivity in the absence of complement and prevents the intercellular spread of infectivity, implying that there is a role for gH in virus entry and exit or in the formation of intercellular junctions (6, 15) . Similar observations have been made with antibody against the VZV homolog (19) . Efficient neutralization of infectivity by antibody to the HCMV homolog suggests that the gH function is conserved among the herpesvirus subgroups, and it now appears likely that gH represents a neutralizing target in all herpesviruses.
